Latest Breaking News On - தேசிய நிறுவனம் க்கு உயிரியல் தரநிலைகள் - Page 3 : comparemela.com

Date Time Anti-coagulant drug could treat COVID-19’s emerging variants Molecules from the same family as the anti-coagulant drug heparin may interfere with the ability of the COVID-19 virus’s spikes to bind to human cells. This could be used to treat people with severe effects of the virus and any emerging variants. New targetable site on the COVID-19 spike protein discovered Heparin-like molecules, a common anti-coagulant, could prevent the virus from infecting cells Low vaccine coverage in many countries means more vaccine-resistant mutations likely to appear. QUT PhD researcher Zachariah Schuurs said the research team had identified a new binding site on the SARS-CoV-2 spike protein.

South africaUnited kingdomZachariah schuursSneha gandhiUniversity of queensland glycochemistryNational institute for biological standardsCollaborators at university of liverpoolKeele universityPersonalised healthCentre for genomicsZucero pharmaceuticalsCurtin university immunologyStructural biotechnology journalCurtin universityNational instituteBiological standards